Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 1463 entries
View as:

Effects of Novel Flash Glucose Monitoring System on Glycemic Control in Adult Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03522870 Org: User:
Start: 05/01/18 End: 06/19/22 Due: 06/19/23

Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02229058 Org: User:
Start: 02/29/12 End: 02/28/17 Due: 02/28/18

Eight Week Clinical Study to Investigate Reduction of Extrinsic Tooth Stain by Electric Toothbrush

Phase: N/A Priority: Normal
NCT ID: NCT05202093 Org: User:
Start: 03/03/22 End: 08/01/22 Due: 08/01/23

TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04103398 Org: User:
Start: 10/02/19 End: 12/31/23 Due: 12/31/24

Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05444478 Org: User:
Start: 07/01/22 End: 07/01/27 Due: 07/01/28

Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06015802 Org: User:
Start: 04/01/21 End: 03/31/29 Due: 03/31/30

IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT02556593 Org: User:
Start: 09/30/15 End: 04/30/19 Due: 04/30/20

Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06281886 Org: User:
Start: 12/01/23 End: 12/01/26 Due: 12/01/27

A Study of Furmonertinib Combined With Radiotherapy for Non-small Cell Lung Cancer With Oligoprogression

Phase: N/A Priority: Normal
NCT ID: NCT04970693 Org: User:
Start: 06/01/21 End: 05/31/24 Due: 05/31/25

Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06383663 Org: User:
Start: 05/01/24 End: 12/31/29 Due: 12/31/30

0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT02595606 Org: User:
Start: 09/30/15 End: 03/31/16 Due: 03/31/17

Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial

Phase: N/A Priority: Normal
NCT ID: NCT04687163 Org: User:
Start: 12/30/20 End: 12/01/22 Due: 12/01/23

A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01462903 Org: User:
Start: 09/30/11 End: 12/31/14 Due: 12/31/15

Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06441565 Org: User:
Start: 05/24/24 End: 12/30/29 Due: 12/30/30

Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06957561 Org: User:
Start: 04/30/25 End: 05/01/29 Due: 05/01/30

Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04423536 Org: User:
Start: 03/09/21 End: 03/31/25 Due: 03/31/26

Study to Evaluate the Protective Effect of α-Keto Acid With Low-protein Diet on Renal Function in PD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00734552 Org: User:
Start: 10/31/07 End: 05/31/10 Due: 05/31/11

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04636632 Org: User:
Start: 11/24/20 End: 11/04/22 Due: 11/04/23

Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer with Different HER2 Expression Patterns

Phase: N/A Priority: Normal
NCT ID: NCT06551220 Org: User:
Start: 10/10/22 End: 01/31/25 Due: 01/31/26

Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00956891 Org: User:
Start: 05/31/05 End: 07/31/10 Due: 07/31/11

Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients

Phase: N/A Priority: Normal
NCT ID: NCT06280495 Org: User:
Start: 02/01/24 End: 12/31/28 Due: 12/31/29

TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02940925 Org: User:
Start: 10/20/16 End: 08/31/21 Due: 08/31/22

Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04562311 Org: User:
Start: 01/01/21 End: 10/30/25 Due: 10/30/26

Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06912074 Org: User:
Start: 04/05/25 End: 04/04/29 Due: 04/04/30

KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT06370026 Org: User:
Start: 05/01/24 End: 12/31/26 Due: 12/31/27